<?xml version="1.0" encoding="UTF-8"?>
<codeBook version="2.5" ID="FRESH-PEF222-en" xml-lang="en" xmlns="ddi:codebook:2_5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="ddi:codebook:2_5 https://ddialliance.org/Specification/DDI-Codebook/2.5/XMLSchema/codebook.xsd">
<docDscr>
  <citation>
    <titlStmt>
      <titl>Registry of general cancers in Lille and its periphery</titl>
      <IDNo>FRESH-PEF222-en</IDNo>
    </titlStmt>
    <prodStmt>
      <producer abbr="" affiliation="HOSPICES CIVILS DE LYON (HCL)" role="">Karine LIGIER</producer>
    </prodStmt>
    <verStmt>
      <version></version>
    </verStmt>
  </citation>
</docDscr>
<stdyDscr>
  <citation>
    <titlStmt>
      <titl>
                Registry of general cancers in Lille and its periphery            </titl>
      <IDNo agency="FReSH-lang">
                FRESH-PEF222-en            </IDNo>
      <IDNo agency="PEF">
                    222                </IDNo>
      <IDNo agency="FReSH">
                    FRESH-PEF222                </IDNo>
    </titlStmt>
    <rspStmt>
      <AuthEnty>
                    Sandrine PLOUVIER                                                                                </AuthEnty>
      <AuthEnty affiliation="centre de r&#xE9;f&#xE9;rence r&#xE9;gional en canc&#xE9;rologie">
                                    </AuthEnty>
      <othId affiliation="" type="">
                                    </othId>
    </rspStmt>
    <prodStmt>
      <prodPlac>
                Epidemiology France Portal (PEF)            </prodPlac>
      <fundAg>
                                            AGENCE REGIONALE DE SANTE HAUTS-DE-FRANCE (ARS)                    
                                    </fundAg>
      <fundAg>
                                            INSTITUT NATIONAL DU CANCER (INCA)                    
                                    </fundAg>
      <fundAg>
                                            REGION HAUTS-DE-France                    
                                    </fundAg>
      <fundAg>
                                            SANTE PUBLIQUE FRANCE                    
                                    </fundAg>
    </prodStmt>
    <distStmt>
      <distrbtr abbr="null">
                    null</distrbtr>
      <contact affiliation="centre de r&#xE9;f&#xE9;rence r&#xE9;gional en canc&#xE9;rologie" email="SPLOUVIER@registrecancers59.fr">
                    Sandrine;PLOUVIER
                                    </contact>
      <depDate date="2026-06-16"/>
      <distDate date="2026-06-16"/>
    </distStmt>
    <biblCit format="">
            </biblCit>
    <holdings URI="null"/>
    <notes> </notes>
  </citation>
  <stdyInfo>
    <studyBudget/>
    <subject>
      <keyword vocab="" vocabURI="">
                    descriptive epidemiology</keyword>
      <keyword vocab="" vocabURI="">
                    incidence</keyword>
      <topcClas vocab="health theme">
                        Oncology                                                        <ExtLink title="ESV" URI="http://data.europa.eu/8mn/euroscivoc/5784b7f1-c7ce-49d9-9f38-aebcda0ff41d"/>
                                                            <ExtLink title="MeSH" URI="http://id.nlm.nih.gov/mesh/D008495"/>
                                                </topcClas>
      <topcClas vocab="cim-11">
                        Neoplasms                                            </topcClas>
      <topcClas vocab="health determinant">
                        Environmental determinants: Other                    </topcClas>
      <topcClas vocab="health determinant">
                        Environmental determinants                    </topcClas>
    </subject>
    <abstract contentType="purpose">Objectives of the registry in terms of public health (surveillance, evaluation) - Produce local statistics for institutions, particularly decision-makers, researchers, associations and the general public, for describing the trends over time of the incidence of cancers and their geographical distribution - with a view to planning and monitoring the efficacy of treatment (prevalence, survival), for the investigation of clusters. - Participate in producing national, regional (Francim) and international (IARC) statistics on cancer: incidence, prevalence and survival. - Evaluate the impact of public health measures (organized screening programs, regional health programs). Objectives of the registry in terms of research - Evaluate medical practices and patient treatment through specific studies conducted from exhaustive and non-biased data produced by the registry (high- resolution studies). - Develop etiological studies, particularly on professional and environmental determining factors of cancer. - Develop studies on the socioeconomic and clinical determining factors of the treatment and survival of cancer patients.</abstract>
    <abstract contentType="abstract">null</abstract>
    <sumDscr>
      <collDate event="start" date="2005-01-01"/>
      <collDate event="end" date="2012-01-01"/>
      <nation abbr="fr">
                    France
                                            <concept vocab="ISO" vocabURI="fr"/>
                                    </nation>
      <geogCover>Hauts-de-France</geogCover>
      <geogUnit/>
      <anlyUnit>
                Individuals            </anlyUnit>
      <universe level="type" clusion="I">Patients population                    </universe>
      <universe level="sex" clusion="I">Male                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D008297"/>
                                                    </universe>
      <universe level="sex" clusion="I">Female                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D005260"/>
                                                    </universe>
      <universe level="age" clusion="I">Infant, Newborn (birth to 28 days)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D007231"/>
                                                    </universe>
      <universe level="age" clusion="I">Infant (28 days to 2 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D007223"/>
                                                    </universe>
      <universe level="age" clusion="I">Child, Preschool (2 to 5 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D002675"/>
                                                    </universe>
      <universe level="age" clusion="I">Child (6 to 12 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D002648"/>
                                                    </universe>
      <universe level="age" clusion="I">Young Adult (19 to 24 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D055815"/>
                                                    </universe>
      <universe level="age" clusion="I">Adult (25 to 44 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D000328"/>
                                                    </universe>
      <universe level="age" clusion="I">Middle Aged (45 to 64 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D008875"/>
                                                    </universe>
      <universe level="age" clusion="I">Aged (65 to 79 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D000368"/>
                                                    </universe>
      <universe level="age" clusion="I">Aged, 80 and over (80 years and more)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D000369"/>
                                                    </universe>
      <universe clusion="I">Tumors diagnosed from January 1st 2005 in adults over the age of 15, living in the area around Lille: - invasive cancers except hematological tumors (except lymphomas included) - in situ of the colon-rectum, breast, cervix, melanoma, thyroid - borderline tumors of the ovaries - benign tumors or tumors of unpredictable progression for tumors of the bladder and  central nervous system, Tumors diagnosed from January 1st 2006: extended to children under the age of 15 and to hematological malignancies                    </universe>
      <dataKind>Clinical data</dataKind>
      <dataKind>Biological data</dataKind>
      <dataKind>Socio-demographic data</dataKind>
      <dataKind>Paraclinical data (non-biological) : Other</dataKind>
    </sumDscr>
  </stdyInfo>
  <studyDevelopment>
    <developmentActivity type="primary evaluation">
      <description>Health event/morbidity
Health event/mortality</description>
    </developmentActivity>
  </studyDevelopment>
  <method>
    <dataColl>
      <sampProc>Other                                                            <concept vocab="CESSDA" vocabURI="Other"/>
                                                    </sampProc>
      <targetSampleSize>
        <sampleSizeFormula>[10000-20000[ individuals                        </sampleSizeFormula>
      </targetSampleSize>
      <collMode>Converting or copying information into a structured record                                                            <concept vocab="CESSDA" vocabURI="Transcription"/>
                                                    </collMode>
    </dataColl>
    <notes>Observational Study</notes>
    <notes subject="research type">
                        Observational Study                    </notes>
    <notes subject="observational study method">
                        Morbidity registry                    </notes>
    <anlyInfo>
      <respRate>environ 4000 cas incidents de cancers par an selon la définition de patients retenue. Le nombre de cas par sexe et topographie de cancer est disponible sur le site Internet du registre : www.registrecancers59.fr Around 4,000 incident cases of cancer per year according to the selected definition of patients. The number of cases per gender and topography of cancer is available on the registry's website: www.registrecancers59.fr</respRate>
    </anlyInfo>
    <stdyClas>Unknown</stdyClas>
  </method>
  <dataAccs>
    <setAvail>
      <avlStatus>
                            Restricted access                                                    </avlStatus>
    </setAvail>
    <useStmt>
      <conditions>The data recorded in the Registry may be used for specific research. A charter defining the cooperation procedure can be downloaded on the registry&amp;#x27;s website.</conditions>
    </useStmt>
  </dataAccs>
  <othrStdyMat>
    <relMat>Free access</relMat>
  </othrStdyMat>
</stdyDscr>
<dataDscr>
</dataDscr></codeBook>
